Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Treatment Study Topical NSAID, PENNSAID and Effect on Coagulation Values in Patients With Osteoarthritis Knee Pain Taking Warfarin
Single Center, Open-label Study of Effect of PENNSAID (Diclofenac Sodium Solution Topical) on Coagulation Parameters (PT, PTT, and INR) in Patients With Moderate to Severe Osteoarthritis Pain of the Knee Taking Anticoagulant Medication
Status: Enrolling
Updated:  2/23/2012
Arthritis Treatment Center
mi
from
Frederick, MD
Treatment Study Topical NSAID, PENNSAID and Effect on Coagulation Values in Patients With Osteoarthritis Knee Pain Taking Warfarin
Single Center, Open-label Study of Effect of PENNSAID (Diclofenac Sodium Solution Topical) on Coagulation Parameters (PT, PTT, and INR) in Patients With Moderate to Severe Osteoarthritis Pain of the Knee Taking Anticoagulant Medication
Status: Enrolling
Updated: 2/23/2012
Arthritis Treatment Center
mi
from
Frederick, MD
Click here to add this to my saved trials
An Acupuncture Functional Magnetic Resonance Imaging (fMRI) Study on Chronic Pain: Response Reliability and Dose Effect
An Acupuncture fMRI Study on Chronic Pain: Response Reliability and Dose Effect
Status: Enrolling
Updated:  2/24/2012
Massachusetts General Hosptial
mi
from
Boston, MA
An Acupuncture Functional Magnetic Resonance Imaging (fMRI) Study on Chronic Pain: Response Reliability and Dose Effect
An Acupuncture fMRI Study on Chronic Pain: Response Reliability and Dose Effect
Status: Enrolling
Updated: 2/24/2012
Massachusetts General Hosptial
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee
A Randomized, Double-Blind, Placebo-controlled Cross-over, Exploratory Trial of Naproxen to Evaluate Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee
Status: Enrolling
Updated:  3/21/2012
Analgesic Solutions
mi
from
Natick, MA
Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee
A Randomized, Double-Blind, Placebo-controlled Cross-over, Exploratory Trial of Naproxen to Evaluate Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee
Status: Enrolling
Updated: 3/21/2012
Analgesic Solutions
mi
from
Natick, MA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Birmingham, AL
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Santa Clara, CA
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Aurora, CO
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Bridgeport, CT
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Metairie, LA
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Baltimore, MD
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Boston, MA
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Rochester, MN
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
St. Joseph, MO
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Omaha, NE
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Newark, NJ
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
New York, NY
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Cleveland, OH
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Tulsa, OK
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Portland, OR
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Dallas, TX
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha �Agent(s)
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated:  4/26/2012
The CORE Institute
mi
from
Sun City West, AZ
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated: 4/26/2012
The CORE Institute
mi
from
Sun City West, AZ
Click here to add this to my saved trials
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated:  4/26/2012
Mission Hospitals Research Institute
mi
from
Asheville, NC
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated: 4/26/2012
Mission Hospitals Research Institute
mi
from
Asheville, NC
Click here to add this to my saved trials
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated:  4/26/2012
Wellington Orthopaedics and Sports Medicine
mi
from
Cincinnati, OH
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated: 4/26/2012
Wellington Orthopaedics and Sports Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated:  4/26/2012
Rosenberg Cooley Metcalf Clinic
mi
from
Park City, UT
Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Status: Enrolling
Updated: 4/26/2012
Rosenberg Cooley Metcalf Clinic
mi
from
Park City, UT
Click here to add this to my saved trials
A Pilot Study to Improve Patient-Doctor Communication
A Pilot Study to Improve Patient-Doctor Communication
Status: Enrolling
Updated:  5/23/2012
Walter Reed National Medical Military Center (WRNMMC)
mi
from
Bethesda, MD
A Pilot Study to Improve Patient-Doctor Communication
A Pilot Study to Improve Patient-Doctor Communication
Status: Enrolling
Updated: 5/23/2012
Walter Reed National Medical Military Center (WRNMMC)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Role of Bone in Knee Osteoarthritis (OA)
The Role of Bone and Its Measurement in Knee Osteoarthritis
Status: Enrolling
Updated:  5/24/2012
New England Baptist Hospital
mi
from
Boston, MA
Role of Bone in Knee Osteoarthritis (OA)
The Role of Bone and Its Measurement in Knee Osteoarthritis
Status: Enrolling
Updated: 5/24/2012
New England Baptist Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Tai Chi and Physical Therapy for Knee Osteoarthritis
Tai Chi and Physical Therapy for Knee Osteoarthritis
Status: Enrolling
Updated:  5/30/2012
Tufts Medical Center
mi
from
Boston, MA
Tai Chi and Physical Therapy for Knee Osteoarthritis
Tai Chi and Physical Therapy for Knee Osteoarthritis
Status: Enrolling
Updated: 5/30/2012
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
Musculoskeletal Ultrasound as a Marker of Therapeutic Response to Abatacept in Rheumatoid Arthritis
Status: Enrolling
Updated:  5/31/2012
UCLA David Geffen School of Medicine, Division of Rheumatology
mi
from
Los Angeles, CA
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
Musculoskeletal Ultrasound as a Marker of Therapeutic Response to Abatacept in Rheumatoid Arthritis
Status: Enrolling
Updated: 5/31/2012
UCLA David Geffen School of Medicine, Division of Rheumatology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Arthritis Foundation Exercise Program & "10 Keys" to Healthy Aging--Prevention Research Center
Arthritis Foundation Exercise Program & "10 Keys" to Healthy Aging
Status: Enrolling
Updated:  6/8/2012
Community sites
mi
from
Allegheny County primarily, PA
Arthritis Foundation Exercise Program & "10 Keys" to Healthy Aging--Prevention Research Center
Arthritis Foundation Exercise Program & "10 Keys" to Healthy Aging
Status: Enrolling
Updated: 6/8/2012
Community sites
mi
from
Allegheny County primarily, PA
Click here to add this to my saved trials
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement
Status: Enrolling
Updated:  7/6/2012
Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement
Status: Enrolling
Updated: 7/6/2012
Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
The CORE Institute
mi
from
Sun City West, AZ
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
The CORE Institute
mi
from
Sun City West, AZ
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
S.T.A.R. Orthopaedics, Inc.
mi
from
La Quinta, CA
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
S.T.A.R. Orthopaedics, Inc.
mi
from
La Quinta, CA
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Orthopaedic Associates of West Florida
mi
from
Clearwater, FL
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Orthopaedic Associates of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
OrthoIndy
mi
from
Indianapolis, IN
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
OrthoIndy
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Bluegrass Orthopaedics and Hand Care
mi
from
Lexington, KY
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Bluegrass Orthopaedics and Hand Care
mi
from
Lexington, KY
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Reconstructive Orthopaedics & Sports Medicine
mi
from
Cincinnati, OH
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Reconstructive Orthopaedics & Sports Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Texas Orthopedic Specialists
mi
from
Bedford, TX
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Texas Orthopedic Specialists
mi
from
Bedford, TX
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Memorial Bone & Joint
mi
from
Houston, TX
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Memorial Bone & Joint
mi
from
Houston, TX
Click here to add this to my saved trials
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated:  7/18/2012
Texas Center for Joint Replacement
mi
from
Plano, TX
Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System
A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System
Status: Enrolling
Updated: 7/18/2012
Texas Center for Joint Replacement
mi
from
Plano, TX
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Cedars-Sinai Orthopedic Center
mi
from
Los Angeles, CA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Cedars-Sinai Orthopedic Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Stanford Orthopedics
mi
from
Redwood City, CA
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Stanford Orthopedics
mi
from
Redwood City, CA
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Colorado Orthopedic Consultants, P.C.
mi
from
Englewood, CO
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Colorado Orthopedic Consultants, P.C.
mi
from
Englewood, CO
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
George Washington University Medical Faculty Associates
mi
from
Washington,
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
George Washington University Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Florida Research Associates, LLC
mi
from
Deland, FL
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Florida Research Associates, LLC
mi
from
Deland, FL
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Phoenix Clinical Research
mi
from
Tamarac, FL
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Phoenix Clinical Research
mi
from
Tamarac, FL
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
St Francis Hospital-Mooresville, Center for Hip & Knee Surgery
mi
from
Mooresville, IN
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
St Francis Hospital-Mooresville, Center for Hip & Knee Surgery
mi
from
Mooresville, IN
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated:  7/19/2012
Joint Replacement Surgeons of Indiana Foundations
mi
from
Mooresville, IN
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Joint Replacement Surgeons of Indiana Foundations
mi
from
Mooresville, IN
Click here to add this to my saved trials